Gilead Sciences, Inc. 8-K Filing Report - February 2025 Insights
Based on the provided XML section of the financial report for Gilead Sciences, Inc., here are the key pieces of information extracted:
- Entity Information:
- Name: Gilead Sciences, Inc.
- State of Incorporation: Delaware (DE)
- CIK (Central Index Key): 0000882095
- SEC File Number: 000-19731
- EIN (Employer Identification Number): 94-3047598
- Address:
- Headquarters: 333 Lakeside Drive, Foster City, CA 94404
- Phone: 650-574-3000
- Stock Information:
- Type of Security: Common Stock
- Par Value: $0.001 per share
- Ticker Symbol: GILD
- Exchange: NASDAQ
- Filing Information:
- Filing Type: 8-K
- Filing Date: February 11, 2025
- Period Covered by the Filing: February 11, 2025
- Other Notes:
- The document is filed in XBRL format, indicating that it is structured for easier data extraction and analysis.
- The filing does not indicate any significant events or changes from the provided section, but it is a routine 8-K filing which typically reports unscheduled material events or corporate changes.
Insights:
- The filing is a routine disclosure from Gilead Sciences, possibly reporting on corporate governance or operational changes as of the date noted.
- The attention to the specific filing format (XBRL) suggests compliance with SEC regulations for transparency and consistency in reporting.
- Investors and analysts may want to monitor subsequent filings or press releases for context regarding any significant developments around the filing date.